Novartis has produced data demonstrating its Zolgensma gene therapy produces long term benefits in the rare muscle wasting disease spinal muscular atrophy – information that will be closely monitored ...

DAVIDSON, NC / ACCESS Newswire / September 10, 2025 / Trane®-by Trane Technologies (NYSE:TT), a global climate innovator, has extended its chiller plant control facility programming application, speci ...